early gastric cancer
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Those who are 20 years of age or older 2. Those who have undergone ESD treatment for early gastric cancer in accordance with the "Stomach Cancer Treatment Guidelines" edited by the Japan Gastric Cancer Society 3. Those taking anticoagulants (warfarin or DOAC) 4. Those who have undergone ESD treatment for early gastric cancer in accordance with the "Guidelines for Gastrointestinal Endoscopy for Patients Taking Antithrombotic Drugs" edited by the Japan Gastroenterological Endoscopy Society or its supplements.
Exclusion criteria
Exclusion criteria: 1. Patients who discontinued ESD or underwent surgical treatment due to complications (bleeding, perforation, etc.) or technical reasons during ESD. 2. Those who have not been able to follow up for more than 28 days after ESD 3. Subjects who received additional photodynamic therapy (PDT) after ESD 4. Patients with infiltration deeper than the muscle layer in histopathological evaluation of the resected specimen 5. Patients participating in other interventional trials 6. Those who refuse to use clinical data
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluation of the postoperative bleeding rate before and after the revised guideline in patients taking antithrombotic drugs during gastric ESD in patients taking anticoagulants. | — |
Countries
Japan
Contacts
National Hospital Organization Kyoto Medical Center Department of gastroenterology